Skip to main content
Helmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logo
Siarhei - stock.adobe.com

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Click & View

Research Highlights

Environmental Health, LHI,

New hope regarding lung diseases

Lung research at Helmholtz Munich has made some spectacular breakthroughs. They could pave the way for the therapy of serious diseases.

read more
Pioneer Campus,

Pioneers of Future Medical Research

Outstanding scientists from all over the world come together at Helmholtz Munich's Pioneer Campus. They bring technologies and ideas that are ground-breaking - and thus open up entirely new perspectives for medical research.

read more
Environmental Health, IEM, Molecular Targets and Therapeutics, VIRO,

In the Battle Against Viruses

During the Corona pandemic, experts from Helmholtz Munich helped to bring the situation under control as quickly as possible. Now they are preparing for the possibility of another pandemic: with new high-tech equipment and closely interlinked…

read more
Computational Health, ITG,

Big Data at Your Bedside

Analysis of genes can help in detecting diseases at an early stage as well as in determining new drug targets for therapy. Thanks to extremely powerful data processing, the field holds great promise for advancement. Helmholtz Munich is particularly…

read more
Computational Health, AIH,

Artificial eagle eyes

In the future, blood samples from patients can be evaluated not only by specialists, but also by artificial intelligence. A team from Helmholtz Munich is laying the foundations for this.

read more
Public Engagement,

In the Front Row

Numerous renowned female researchers work at Helmholtz Munich. Ensuring that female scientists receive the best support for their careers is an important element in promoting excellence.

read more
Public Engagement,

Knowledge Fosters Health!

How do I stay healthy? What impact do my environment and lifestyle have on my health? And how can I prevent, treat, or even cure chronic diseases like diabetes, allergies, or lung diseases?

read more
Transfer,

"A startup can be just as big a success as a Leibniz Prize!"

Matthias Tschöp, CEO of Helmholtz Munich, talks about translating scientific discoveries into clinical practice, about ambitious targets, and about ideas he acquired during his time in the USA.

read more
Stem Cells, IES,

Understanding Embryonic Development

The ability to reprogram cells holds great promises for regenerative medicine. Cells from the embryo at the beginning of life divide and produce all cell types in the body. What can embryos teach us so that we can generate cells ‘à la carte’ to cure…

read more
Pioneer Campus,

Organ-on-Chip: Micro-Organs for Personalised Cell Therapy

They fit in the palm of your hand – tiny mini-labs that researchers at Helmholtz Munich want to use to shape the medicine of tomorrow. “Organ-on-chip” is the key word. This approach combines engineering and biology, not only making it easier to…

read more
Transfer, Diabetes, IDR, IDF,

Our Partnerships for a World Without Diabetes

Researchers at Helmholtz Munich are working toward a world without diabetes. They are not doing so alone, but with a network of organizations, hospitals, and pharmaceutical companies. Their goal is to use experts’ knowledge to create something new:…

read more
Environmental Health, IEM,

One Health: Climate Change Triggers Common Diseases

Rising temperatures accelerate processes: The simple rule of thumb taught in chemistry classes and known as reaction velocity-temperature-regulation, also applies in a broader sense to the effects of global warming on risk groups and sensitive…

read more
Diabetes, IDF,

Early Detection Tests for a World Without Type 1 Diabetes

At Helmholtz Munich, scientists are working to ensure that no child will have to suffer from the autoimmune disease type 1 diabetes in the future.

read more
Computational Health,

How AI is Revolutionizing Medicine

Computer systems can already independently analyze health data, learn from it and even derive therapy recommendations. Which opportunities this means for patients and what research needs to apply artificial intelligence in practice.

read more
Molecular Targets and Therapeutics, STB,

Hope in the Fight Against Parasites

Every year, millions of people fall ill with Chagas or sleeping sickness. Both diseases are caused by parasites that are spreading from tropical countries to Europe. Researchers have discovered a weak spot in those parasites, which may be a key to a…

read more
Environmental Health, IAP,

The Farm Effect

Many children suffer from asthma or allergies. Early and effective prevention of these diseases is the declared goal of science. Which research strategies do scientists pursue and what part does cow barn play in this story?

read more

Research News

Awards & Grants, Environmental Health, PGSB,

ERC Grant for RESIST: Drought Stress Resistance in Oat for a Changing Climate

Ensuring the sustainability of oat cultivation as a significant future food source holds great promises for both human health and the climate. Dr. Nadia Kamal, a researcher at the Plant Genome and Systems Biology Group at Helmholtz Munich, has been…

read more
Awards & Grants, Diabetes, IDR,

Advancing Stem Cell-Based Therapy for Type 1 Diabetes

Helmholtz Munich researchers receive 2.25 Mio US Dollar JDRF Grant 

With a 2.25 million US dollar grant provided by the Juvenile Diabetes Research Foundation (JDRF), Prof. Matthias Hebrok, Prof. Heiko Lickert, and Prof. Carolin Daniel from the…

read more
Awards & Grants, Computational Health,

AI and Machine Learning in Genomics

Helmholtz Munich and the Eric and Wendy Schmidt Center at the Broad Institute launch Collaborative Research Initiative

Helmholtz Munich and the Eric and Wendy Schmidt Center at the Broad Institute of MIT and Harvard announced the launch of a…

read more
New Research Findings, ICB, Molecular Targets and Therapeutics,

Aggressive Blood Cancer: Contribution of Enzyme MALT1 Uncovered

A team of researchers from Helmholtz Munich in cooperation with scientists at the University Hospital Münster (UKM) has uncovered a new pathway that promotes the growth of aggressive blood cancer, so-called lymphomas. Survival of many lymphomas…

read more
Awards & Grants, Pioneer Campus,

Honoring Aspiring Research: Na Cai Received the Friedmund Neumann Prize 2023

Dr. Na Cai, Principal Investigator at the Helmholtz Pioneer Campus and at the Computational Health Center at Helmholtz Munich, has been honored with this year's Friedmund Neumann Prize awarded by the Schering Foundation. The prize recognizes…

read more
New Research Findings, Bioengineering, ITERM,

A New Ally in Fighting Brain Diseases: Our Very Own Skull

Alzheimer's, stroke, multiple sclerosis and other neurological diseases cause severe damage due to neuroinflammation mediated by immune cells. Managing this inflammation poses a significant medical challenge because the brain is protected by the…

read more
Transfer, Pioneer Campus,

Life Science Factory to Open a New Location at Helmholtz Munich in 2024

The Life Science Factory incubator initiated by Sartorius in Göttingen and the top biomedical research center Helmholtz Munich are entering into a strategic partnership to support spin-offs in the life sciences. Within this framework, the Life…

read more
Awards & Grants, Environmental Health, IAP,

Erika von Mutius receives Bavarian Maximilian Order

Prof. von Mutius is one of nine exceptional individuals who have been awarded the "Bavarian Nobel Prize" this year for their outstanding work in the fields of science and art.

read more
Transfer, Awards & Grants, Environmental Health, PGSB,

New Hope for Bavarian Hop Cultivation: PANHOP Project Aims to Breed Resistant Varieties

The foundations for resistant varieties are being developed through genome-assisted breeding and decoding of the complex hop genome as part of the new research project PANHOP at Helmholtz Munich. These varieties should counteract the effects of…

read more
Awards & Grants, Computational Health,

Michael Zech Awarded for Discovering New Hereditary Form of Dystonia

Dr. Michael Zech received the David Marsden Award 2023 from Dystonia Europe at the 9th EAN Congress in Budapest, Hungary. The award recognizes his groundbreaking research on the genetics of movement disorders, particularly dystonia.

read more
New Research Findings, Bioengineering, ITERM,

WildDISCO: Visualizing Whole Bodies in Unprecedented Detail

Researchers developed a new method called wildDISCO that uses standard antibodies to map the entire body of an animal using fluorescent markers. This revolutionary technique provides detailed 3D maps of structures, shedding new light on complex…

read more
Public Engagement, Diabetes, EPI,

Climate change and heat: What is the impact on people with diabetes?

The increase in heat periods as a result of climate change can be more critical for people with diabetes than for metabolically healthy people. This is especially true at older ages. The article "Heat and diabetes" from diabinfo.de deals with helpful…

read more
Porträt: Prof. Fabian Theis
Computational Health, ICB,

AI Expert Prof. Fabian Theis boosts Helmholtz Pioneer Campus

Prof. Fabian Theis, the AI expert, Director of the Computational Health Center at Helmholtz Munich, and Coordinator of Helmholtz AI takes on another important role for AI-based medical research: As Director for Biomedical AI, he complements the…

read more
Awards & Grants, Computational Health, ICB,

Honoring Outstanding AI-based Biomedical Research: Fabian Theis Elected as ISCB Fellow

The International Society for Computational Biology (ISCB) annually recognizes exceptional individuals in the fields of computational biology and bioinformatics through its prestigious Fellows program. This year, Prof. Fabian Theis, Head of the…

read more
Awards & Grants, Diabetes, IDO,

Transformative Drugs Discovered: Matthias Tschöp Wins Major US Award

For major breakthroughs, the American Diabetes Association (ADA) awards its highest honor, the Banting Medal for Scientific Achievement named after the nobel laureate and discoverer of insulin, Frederick Banting. Helmholtz Munich CEO and Humboldt…

read more
Awards & Grants, Environmental Health, LHI, ITERM,

Best Scientific Image Contest 2023: Scientists From Helmholtz Munich Awarded

In January 2023, Helmholtz Imaging called for the Best Scientific Image for the third consecutive time. The winners were announced during the award ceremony on June 15, 2023, at the 3rd Annual Helmholtz Imaging Conference 2023. Lin Yang from the…

read more
Awards & Grants, HI-MAG, Pioneer Campus,

For a Healthier Society: HI-MAG Celebrates 5th Anniversary

Investigating Metabolic, Obesity and Vascular Diseases

 

The Helmholtz Institute for Metabolic, Obesity and Vascular Research (Helmholtz-Institut für Metabolismus-, Adipositas- und Gefäßforschung, HI-MAG), an institute from Helmholtz Munich at the…

read more
New Research Findings, Computational Health, ICB,

First Integrated Single-Cell Atlas of the Human Lung

Can a human organ be mapped on a single-cell level to learn about the functionality of each individual cell? And can we learn how different these cells are from person to person? Helmholtz Munich researchers and their collaborators have taken up this…

read more
Transfer, Molecular Targets and Therapeutics, Pioneer Campus,

Helmholtz Munich Establishes State-of-the-Art Cryo-Electron Microscopy Technology

Enabling Breakthroughs in High-Resolution Structural Analysis of Therapeutic Targets and their Visualization in the Native Cellular Context

read more
New Research Findings, Environmental Health, EPI,

Ambient ultrafine particles – very small and very dangerous?

A new study conducted by Helmholtz Munich researchers reveals that ultrafine particles, representing the smallest size fraction of particulate air pollution, might be more dangerous to human health than larger particles. These findings add to the…

read more

Our Research Centers

Helmholtz Diabetes Center

Computational Health Center

Stem Cell Center

Environmental Health Center

Bioengineering Center

Molecular Targets and Therapies Center

Helmholtz Pioneer Campus

Core Facilities

Core Facilities

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Helmholtz Munich / Matthias Balk

Transfer

©Helmholtz Munich / Ertürk lab

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information

Our Researchers

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Prof. Dr. Stephan Herzig

Director of the Diabetes Center

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

to Erika´s page

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

Networks

Helmholtz

German Center for Diabetes Research

German Center for Lung Research